Teva Pharmaceutical Industries (TEVA) Leases: 2018-2025
Historic Leases for Teva Pharmaceutical Industries (TEVA) over the last 7 years, with Sep 2025 value amounting to $342.0 million.
- Teva Pharmaceutical Industries' Leases fell 6.04% to $342.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $342.0 million, marking a year-over-year decrease of 6.04%. This contributed to the annual value of $367.0 million for FY2024, which is 7.56% down from last year.
- Teva Pharmaceutical Industries' Leases amounted to $342.0 million in Q3 2025, which was down 4.47% from $358.0 million recorded in Q2 2025.
- In the past 5 years, Teva Pharmaceutical Industries' Leases registered a high of $531.0 million during Q2 2021, and its lowest value of $342.0 million during Q3 2025.
- Over the past 3 years, Teva Pharmaceutical Industries' median Leases value was $364.0 million (recorded in 2024), while the average stood at $377.9 million.
- As far as peak fluctuations go, Teva Pharmaceutical Industries' Leases surged by 585.14% in 2021, and later dropped by 16.95% in 2022.
- Teva Pharmaceutical Industries' Leases (Quarterly) stood at $495.0 million in 2021, then declined by 15.35% to $419.0 million in 2022, then dropped by 5.25% to $397.0 million in 2023, then dropped by 7.56% to $367.0 million in 2024, then fell by 6.04% to $342.0 million in 2025.
- Its last three reported values are $342.0 million in Q3 2025, $358.0 million for Q2 2025, and $363.0 million during Q1 2025.